+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
CSL Behring - logo

CSL Behring is a global leader in the plasma protein biotherapeutics industry. It specializes in bleeding disorder, fluid replacement, hereditary angioedema, immunoglobulin, pulmonary, and wound healing biotherapies. Its therapies are being used to treat coagulation disorders, primary immune deficiencies, neurological conditions, inherited respiratory diseases and a variety of others. The company was founded in 2000 and is based in King of Prussia, Pennsylvania.

From
From
Blood Plasma - Global Strategic Business Report - Product Thumbnail Image

Blood Plasma - Global Strategic Business Report

  • Report
  • July 2025
  • 282 Pages
  • Global
From
From
Rare Hematology - Global Strategic Business Report - Product Thumbnail Image

Rare Hematology - Global Strategic Business Report

  • Report
  • July 2025
  • 194 Pages
  • Global
From
From
Autoimmune Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2025

  • Report
  • April 2025
  • 500 Pages +
  • Global
From
Alpha-1 Antitrypsin Drugs - Global Strategic Business Report - Product Thumbnail Image

Alpha-1 Antitrypsin Drugs - Global Strategic Business Report

  • Report
  • July 2025
  • 193 Pages
  • Global
From
From
Delivery Systems for Repositioning IV Therapeutics - Product Thumbnail Image

Delivery Systems for Repositioning IV Therapeutics

  • Report
  • December 2021
  • 95 Pages
  • Global
From
Global Markets for Blood Plasma Products - Product Thumbnail Image

Global Markets for Blood Plasma Products

  • Report
  • February 2023
  • 144 Pages
  • Global
From
From
Viral Vector Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Viral Vector Collaboration and Licensing Deals 2016-2025

  • Report
  • May 2025
  • 250 Pages
  • Global
From
Lung Transplant Rejection - Pipeline Insight, 2025 - Product Thumbnail Image

Lung Transplant Rejection - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
Loading Indicator